The clinical trials market in Poland is growing, but at a moderate pace
Development forecasts for 2012-2014'', the clinical trials market in Poland will grow at a moderate pace, by approximately 5% per annum, to PLN 860m in 2014.
Italian scientists say the benefits of some cancer drugs may be exaggerated as a rising number of trials are stopped early.